[Skip to Navigation]
Sign In
Viewpoint
February 2, 2016

Role of the FDA in Affordability of Off-Patent Pharmaceuticals

Author Affiliations
  • 1Department of Medicine and Institute of the History of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland
  • 2Department of Health Policy and Management, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland
JAMA. 2016;315(5):461-462. doi:10.1001/jama.2015.18720
Add or change institution
×